Menorrhagia, or heavy menstrual bleeding, is defined as menstrual blood loss greater than 80ml over several cycles. It is a common cause of iron deficiency anemia in women. Potential causes include physiological changes, dysfunctional uterine bleeding, fibroids, polyps, infections, blood disorders, and iatrogenic factors. Evaluation involves a history, examination, blood tests, ultrasound, and possibly endometrial biopsy. Treatment depends on underlying cause but may include NSAIDs, antifibrinolytics, contraceptive pills, progestogen therapies, endometrial ablation or resection, and hysterectomy.
In the UKâŠEach year causes 1 in 20 women between 30-49yrs to visit their GP Commonest cause of iron deficiency anaemia in women of reproductive age
4.
Interesting Facts Tenfoldincrease in number of periods women experience (reducing family size, less lactation, early menarche, late menopause) If loss >60mls, neg iron balance can occur Clinicians rely on womanâs assessment of menstrual blood loss, which may be inaccurate in 50% cases
5.
History Full gynaecologicalhistory Notoriously inaccurate amount of blood loss Number of pads/tampons used Clots/ flooding Frequency of accidents Menstrual chart can be useful
6.
Examination Weight Anysigns of endocrine disturbance Abdominal and pelvic examination Cervical smear if indicated
7.
NICE Referral GuidelinesIf there is suspicion of underlying cancer They also have persistant intermenstrual or postcoital bleeding Despite 3 months of drug treatment the bleeding is still heavy and interfering with quality of life Wish to explore the possibility of surgical intervention rather than persist with drugs They have severe anaemia failing to respond to drugs
8.
Pathophysiology Menstrual bleedingeither ovulatory or anovulatory Regular and painful- ovulatory Irregular and painless- anovulatory With menorrhagia there is evidence of elevated levels of prostaglandins in endometrium and altered responsiveness to vasodilator PGE2.
9.
Pathophysiology Ovulatory bleedingis associated with normal levels of circulating progesterone and oestradiol, therefore altered prostaglandin synthesis is thought to be responsible for increased menstrual loss Ratio of PGE2 and prostacyclin (causing vasodilatation and inhibition of platelet aggregation) and PGF2a (promoting vasoconstriction and platelet aggregation) is significant
10.
Aetiology Physiological- normalloss but interpreted as excessive. Commonly occuring in those who stop the OCP Dysfunctional Uterine Bleeding- diagnosis made after pelvic pathology excluded Congenital- increased endometrial surface area, eg bicornuate uterus Traumatic, eg. IUD
Investigations Full bloodcount Thyroid function tests, clotting profiles If suspect infection- endocervical swabs Vaginal Ultrasonography- measure thickness of endometrium (<5mm normal). Detects abnormalities of the cavity eg.polyps. Can assess ovaries and uterus
13.
Investigations Endometrial biopsyshould be performed if- menorrhagia is a recent phenomenon woman over 40 yrs if there is any intermenstrual bleeding Even if procedure is performed via D&C it is diagnostic and NOT therapeutic
14.
Treatment If anypathology is found it must be treated, rest aim to treat dysfunctional uterine bleeding Anovulatory- extremes of age. OCP can help. Cyclical progestogens used to induce regular withdrawl bleeds. If these stop, woman has reached menopause Acute arrest for heavy bleeding- high dose reducing course of progestogen
15.
Treatment NSAIDS- inhibitsynthesis of prostaglandins, decrease blood loss by up to 30%. Mefanamic acid, given for a few days during menstruation Antifibrinolytic drugs- reduce enhanced fibrinolytic activity within the uterus. Up to 50% reduction. Tranexamic acid Oral Contraceptive Pill- ovulation suppressed and oestrogen levels remain constant.
16.
Treatment Hormone releasingIUDâs- progestogen released causes atrophy of endometrium. Can cause amenorrhoea Danazol- anti gonadotrophin. Induces atrophy of endometrium due to low level of circulating sex steroids. Androgenic side effects not tolerated well- virilizing effects
17.
Treatment Endometrial ablationor resection- visualised hysteroscopically and ablated. Many methods-laser, rollerball, hydrothermal, cryoablation, microwave. Can become amenorrhoeic but not always successful Hysterectomy- definative treatment if family complete.